Dabrafenib and Trametinib With Radiosurgery in Melanoma Brain Mets

NCT01721603 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

BRAFV600E Melanoma Patients

Interventions

DRUG: Dabrafenib
PROCEDURE: Gamma Knife Radiosurgery
DRUG: Trametinib

Sponsor

University of California, San Francisco

Collaborators

[object Object]